{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:02:10Z","timestamp":1787162530127,"version":"build-2736575974"},"reference-count":44,"publisher":"The Endocrine Society","issue":"3","license":[{"start":{"date-parts":[[2024,8,31]],"date-time":"2024-08-31T00:00:00Z","timestamp":1725062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Catecholamine-producing tumors of childhood include neuroblastic tumors, phaeochromocytoma, and paraganglioma (PPGL). PPGL and neuroblastic tumors can arise in similar anatomical locations and clinical presentations can overlap, resulting in diagnostic challenges. Distinguishing between these tumor types is critical as management and long-term surveillance strategies differ depending on the diagnosis. Herein we describe 2 clinical cases and illustrate key considerations in the diagnostic workup of a neuroblastoma vs PPGL for patients presenting with adrenal, pelvic, and retroperitoneal masses in childhood.<\/jats:p>","DOI":"10.1210\/clinem\/dgae603","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T20:37:25Z","timestamp":1724963845000},"page":"855-862","source":"Crossref","is-referenced-by-count":1,"title":["Approach to the Paediatric Patient With Suspected Pheochromocytoma or Paraganglioma Versus Neuroblastoma"],"prefix":"10.1210","volume":"110","author":[{"given":"A Emile J","family":"Hendriks","sequence":"first","affiliation":[{"name":"Department of Paediatric Endocrinology, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]},{"name":"Department of Paediatrics, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Burns","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology and Oncology, Cambridge University Hospital , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Fleming","sequence":"additional","affiliation":[{"name":"Department of Radiology, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Harper","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hook","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Armstrong","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , 01307 Dresden ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8601-9903","authenticated-orcid":false,"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine III, University Hospital Carl Gustav Carus, Technische Universit\u00e4t Dresden , 01307 Dresden ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4480-1147","authenticated-orcid":false,"given":"Matthew J","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Paediatric Haematology and Oncology, Cambridge University Hospital , Cambridge CB2 0QQ ,","place":["UK"]},{"name":"Department of Pathology, University of Cambridge , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4058-3135","authenticated-orcid":false,"given":"Ruth T","family":"Casey","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Cambridge University Hospitals NHS Foundation Trust , Cambridge CB2 0QQ ,","place":["UK"]},{"name":"Department of Medical Genetics, Cambridge University , Cambridge CB2 0QQ ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,8,31]]},"reference":[{"issue":"1","key":"2025021815510581500_dgae603-B1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"2025021815510581500_dgae603-B2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1353.003","article-title":"Characteristics of pheochromocytoma in a 4- to 20-year-old population","volume":"1073","author":"Barontini","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"23","key":"2025021815510581500_dgae603-B3","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"2025021815510581500_dgae603-B4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-term prognosis of patients with pediatric pheochromocytoma","volume":"21","author":"Bausch","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2025021815510581500_dgae603-B5","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/jpsu.2001.21612","article-title":"Pheochromocytoma in children","volume":"36","author":"Ciftci","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"4","key":"2025021815510581500_dgae603-B6","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","article-title":"Characteristics of pediatric vs adult pheochromocytomas and paragangliomas","volume":"102","author":"Pamporaki","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021815510581500_dgae603-B7","doi-asserted-by":"crossref","first-page":"918435","DOI":"10.3389\/fendo.2022.918435","article-title":"Adrenocortical tumors and pheochromocytoma\/paraganglioma initially mistaken as neuroblastoma-experiences from the GPOH-MET registry","volume":"13","author":"Kuhlen","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9486","key":"2025021815510581500_dgae603-B8","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","author":"Lenders","year":"2005","journal-title":"Lancet"},{"issue":"4","key":"2025021815510581500_dgae603-B9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1530\/EJE-19-0159","article-title":"Pheochromocytoma and paraganglioma: clinical feature-based disease probability in relation to catecholamine biochemistry and reason for disease suspicion","volume":"181","author":"Geroula","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2025021815510581500_dgae603-B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12020-010-9319-3","article-title":"Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma","volume":"37","author":"King","year":"2010","journal-title":"Endocrine"},{"issue":"08","key":"2025021815510581500_dgae603-B11","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1055\/s-0042-106725","article-title":"Attention deficit hyperactivity disorder in pediatric patients with pheochromocytoma and paraganglioma","volume":"48","author":"Batsis","year":"2016","journal-title":"Horm Metab Res"},{"issue":"1","key":"2025021815510581500_dgae603-B12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1196\/annals.1296.027","article-title":"Leaky catecholamine stores: undue waste or a stress response coping mechanism?","volume":"1018","author":"Eisenhofer","year":"2004","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"2025021815510581500_dgae603-B13","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors","volume":"83","author":"Eisenhofer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2025021815510581500_dgae603-B14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejca.2016.12.002","article-title":"Catecholamines profiles at diagnosis: increased diagnostic sensitivity and correlation with biological and clinical features in neuroblastoma patients","volume":"72","author":"Verly","year":"2017","journal-title":"Eur J Cancer"},{"key":"2025021815510581500_dgae603-B15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejca.2019.01.014","article-title":"Catecholamine excretion profiles identify clinical subgroups of neuroblastoma patients","volume":"111","author":"Verly","year":"2019","journal-title":"Eur J Cancer"},{"issue":"3829","key":"2025021815510581500_dgae603-B16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.160.3829.767","article-title":"Tyramine-H 3\u202f: deaminated metabolites in neuroblastoma tumors and in continuous cell line of a neuroblastoma","volume":"160","author":"Goldstein","year":"1968","journal-title":"Science"},{"issue":"6","key":"2025021815510581500_dgae603-B17","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025021815510581500_dgae603-B18","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated O-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"issue":"4","key":"2025021815510581500_dgae603-B19","doi-asserted-by":"crossref","first-page":"G641","DOI":"10.1152\/ajpgi.1995.268.4.G641","article-title":"Production and metabolism of dopamine and norepinephrine in mesenteric organs and liver of swine","volume":"268","author":"Eisenhofer","year":"1995","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"2025021815510581500_dgae603-B20","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1210\/jcem.82.11.4339","article-title":"Substantial production of dopamine in the human gastrointestinal tract","volume":"82","author":"Eisenhofer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025021815510581500_dgae603-B21","doi-asserted-by":"crossref","first-page":"e28081","DOI":"10.1002\/pbc.28081","article-title":"Biochemical testing for neuroblastoma using plasma free 3-O-methyldopa, 3-methoxytyramine, and normetanephrine","volume":"67","author":"Peitzsch","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"2025021815510581500_dgae603-B22","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clinbiochem.2019.02.012","article-title":"Plasma free metanephrines for diagnosis of neuroblastoma patients","volume":"66","author":"Barco","year":"2019","journal-title":"Clin Biochem"},{"key":"2025021815510581500_dgae603-B23","doi-asserted-by":"crossref","first-page":"901760","DOI":"10.3389\/fendo.2022.901760","article-title":"Biochemical diagnosis of catecholamine-producing tumors of childhood: neuroblastoma, pheochromocytoma and paraganglioma","volume":"13","author":"Eisenhofer","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"2025021815510581500_dgae603-B24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.trecan.2017.11.001","article-title":"Genomic landscape of pheochromocytoma and paraganglioma","volume":"4","author":"Jochmanova","year":"2018","journal-title":"Trends Cancer"},{"issue":"2","key":"2025021815510581500_dgae603-B25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"4","key":"2025021815510581500_dgae603-B26","doi-asserted-by":"crossref","first-page":"a002584","DOI":"10.1101\/mcs.a002584","article-title":"Germline SDHA mutations in children and adults with cancer","volume":"4","author":"Dubard Gault","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"issue":"3","key":"2025021815510581500_dgae603-B27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B -associated pheochromocytomas and paragangliomas","volume":"92","author":"Timmers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"2025021815510581500_dgae603-B28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European network for the study of adrenal tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"issue":"4","key":"2025021815510581500_dgae603-B29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/383253","article-title":"Germline mutations of the paired-like homeobox 2B (PHOX2B) gene in neuroblastoma","volume":"74","author":"Trochet","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"7215","key":"2025021815510581500_dgae603-B30","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nature07261","article-title":"Identification of ALK as a major familial neuroblastoma predisposition gene","volume":"455","author":"Moss\u00e9","year":"2008","journal-title":"Nature"},{"issue":"2","key":"2025021815510581500_dgae603-B31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/1573396314666180129101627","article-title":"Biological and genetic features of neuroblastoma and their clinical importance","volume":"14","author":"Aygun","year":"2018","journal-title":"Curr Pediatr Rev"},{"issue":"2","key":"2025021815510581500_dgae603-B32","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0002-9440(10)64547-6","article-title":"Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas","volume":"157","author":"Dannenberg","year":"2000","journal-title":"Am J Pathol"},{"key":"2025021815510581500_dgae603-B33","doi-asserted-by":"crossref","first-page":"609263","DOI":"10.3389\/fendo.2021.609263","article-title":"Case report: pheochromocytoma and synchronous neuroblastoma in a family with hereditary pheochromocytoma associated with a MAX deleterious variant","volume":"12","author":"Duarte","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"9","key":"2025021815510581500_dgae603-B34","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00247-018-4117-9","article-title":"A review of neuroblastoma image-defined risk factors on magnetic resonance imaging","volume":"48","author":"Chen","year":"2018","journal-title":"Pediatr Radiol"},{"issue":"3","key":"2025021815510581500_dgae603-B35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ejrad.2010.05.041","article-title":"CT characteristics of primary retroperitoneal neoplasms in children","volume":"75","author":"Xu","year":"2010","journal-title":"Eur J Radiol"},{"issue":"6","key":"2025021815510581500_dgae603-B36","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2214\/ajr.155.6.2173385","article-title":"Extraadrenal retroperitoneal paraganglioma: clinical, pathologic, and CT findings","volume":"155","author":"Hayes","year":"1990","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2025021815510581500_dgae603-B37","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s12957-023-03011-y","article-title":"Metastasis pattern and prognosis in children with neuroblastoma","volume":"21","author":"Liu","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"2","key":"2025021815510581500_dgae603-B38","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2967\/jnmt.122.264694","article-title":"68Ga-DOTATATE PET in restaging and response to therapy in neuroblastoma: a case series and a Mini review","volume":"51","author":"AlSadi","year":"2023","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"2025021815510581500_dgae603-B39","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00259-010-1720-x","article-title":"Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr 3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine","volume":"38","author":"Kroiss","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"10","key":"2025021815510581500_dgae603-B40","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of nuclear medicine practice guideline\/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"2025021815510581500_dgae603-B41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<364::AID-CNCR21>3.0.CO;2-7","article-title":"The international neuroblastoma pathology classification (the shimada system)","volume":"86","author":"Shimada","year":"1999","journal-title":"Cancer"},{"key":"2025021815510581500_dgae603-B42","doi-asserted-by":"crossref","first-page":"1066208","DOI":"10.3389\/fendo.2022.1066208","article-title":"The use of temozolomide in paediatric metastatic phaeochromocytoma\/paraganglioma: a case report and literature review","volume":"13","author":"Urquhart","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"29","key":"2025021815510581500_dgae603-B43","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: a report from the Children's oncology group","volume":"39","author":"Irwin","year":"2021","journal-title":"J Clin Oncol"},{"issue":"9579","key":"2025021815510581500_dgae603-B44","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(07)60983-0","article-title":"Neuroblastoma","volume":"369","author":"Maris","year":"2007","journal-title":"Lancet"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae603\/59150751\/dgae603.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/855\/59150751\/dgae603.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/3\/855\/59150751\/dgae603.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:13:53Z","timestamp":1739877233000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/3\/855\/7746453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,31]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,8,31]]},"published-print":{"date-parts":[[2025,2,18]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae603","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3]]},"published":{"date-parts":[[2024,8,31]]}}}